Denise O'Dea, NP: Maintaining Current Dosage and Getting Adequate Nursing and Support
Watch
Denise O'Dea, NP: Managing Adverse Events Such as Rash and Stomatitis
Denise O'Dea, NP: Concern About Potential Drug Interactions
Denise O'Dea, NP: Use of TKI Therapy in Patients with EGRF Exon 21 Substitutions (L858R)
Corey J. Langer, MD: Options for Treatment and Reimbursement
Corey J. Langer, MD: Maintaining Current Dosage and Getting Adequate Nursing and Support
Corey J. Langer, MD: Managing Adverse Events Such as Rash and Stomatitis
Corey J. Langer, MD: Concern About Potential Drug Interactions
Corey J. Langer, MD: Use of TKI Therapy in Patients with EGRF Exon 21 Substitutions (L858R)
David Spigel, MD: Options for Treatment and Reimbursement
David Spigel, MD: Maintaining Current Dosage and Getting Adequate Nursing and Support
David Spigel, MD: Managing Adverse Events Such as Rash and Stomatitis
David Spigel, MD: Concern About Potential Drug Interactions
David Spigel, MD: Use of TKI Therapy in Patients with EGRF Exon 21 Substitutions (L858R)
Metastatic NSCLC with Corey J. Langer, MD, David Spigel, MD, Denise O'Dea, NP, and Jack West, MD: Case 1
Metastatic NSCLC with Corey J. Langer, MD, David Spigel, MD, Denise O'Dea, NP, and Jack West, MD
Jack West, MD: Options for Treatment and Reimbursement After Dose Reduction
Jack West, MD: Concern About Drug Interactions
Jack West, MD: Clinical Criteria for Dose Reduction
Jack West, MD: Recommendations for Managing the Principle Adverse Event of Diarrhea
Jack West, MD: Use of TKI Therapy in Patients with EGRF Exon 19 Deletion NSCLC
Denise O'Dea: Options for Treatment and Reimbursement After Dose Reduction
Denise O'Dea, NP: Concern About Drug Interactions
Denise O'Dea, NP: Clinical Criteria for Dose Reduction
Denise O'Dea, NP: Recommendations for Managing the Principle Adverse Event of Diarrhea
Denise O'Dea, NP: Use of TKI Therapy in Patients with EGRF Exon 19 Deletion NSCLC
Corey J. Langer, MD: Options for Treatment and Reimbursement After Dose Reduction
Corey J. Langer, MD: Concern About Drug Interactions
Corey J. Langer, MD: Clinical Criteria for Dose Reduction
Corey J. Langer, MD: Recommendations for Managing the Principle Adverse Event of Diarrhea
Corey J. Langer, MD: Use of TKI Therapy in Patients With EGRF Exon 19 Deletion NSCLC
